We have also previously reported that activin production is significantly altered in stage IV CRC specifically; therefore, future studies should include stage IV patients in the quantification of activin and TGF-β, as these patients may have the greatest level of dysregulation [33]. The gene discussed is INHBE; the disease is colorectal carcinoma.